Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Epilepsy

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy

Registered drug

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Levetiracetam

Contact Research Centre

Chronic graft versus host disease

Not recruiting

InvestigationalNo placebo

Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

InvestigationalNo placebo

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Partial seizures

Not recruiting

Investigational

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Bhv-7000

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Relapsing-remitting multiple sclerosis

Not recruiting

Investigational

Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

Investigational

Greece

Participants:18–64 years
Substances:Obexelimab

Contact Research Centre

Myasthenia gravis

Not recruiting

Registered drug

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on the Effects and Safety of Buloxibutid for Patients with Idiopathic Pulmonary Fibrosis

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Buloxibutid

Contact Research Centre

Lung neoplasm malignant

Not recruiting

Registered drug

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Find therapies in clinical trials near you – page 13

166 trials match your criteria

Epilepsy

Study on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy

Chronic graft versus host disease

Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

Squamous cell carcinoma of head and neck

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Squamous cell carcinoma of head and neck

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Squamous cell carcinoma of head and neck

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Partial seizures

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Transitional cell carcinoma

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Relapsing-remitting multiple sclerosis

Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

Myasthenia gravis

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Idiopathic pulmonary fibrosis

Study on the Effects and Safety of Buloxibutid for Patients with Idiopathic Pulmonary Fibrosis

Lung neoplasm malignant

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Non-small cell lung cancer metastatic

Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.